In this study, based on visual inspection curves of estimated survival dependent on CXCL10 and CXCL9 expression, we integrated multiple datasets with gene expression, which contained 1,673 cases in total to explore ovarian cancer TME immunological characteristics from immune signature gene sets. The gene discussed is CXCL9; the disease is ovarian cancer.